Rankings
▼
Calendar
INMB (INmune Bio, Inc.) Stock Financials & Earnings | Market Cap Arena
INMB
INmune Bio, Inc.
Mkt Cap
$35M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$50,000
Net Income (TTM)
-$50M
EPS (TTM)
-$2.13
Free Cash Flow (TTM)
-$32M
Gross Margin
44.0%
Op. Margin
-102752.0%
Net Margin
-99774.0%
FCF Margin
-63100.0%
P/S Ratio (TTM)
707.2x
P/E Ratio (TTM)
—
YoY Rev Growth
+19.0%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 26
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$97K
$97K
-$6M
Q1 23
$38K
$38K
-$6M
Q2 23
$46K
$46K
-$6M
Q3 23
$43K
$43K
-$9M
Q4 23
$28K
$28K
-$8M
Q1 24
$14K
$14K
-$11M
Q2 24
$0
$0
-$10M
Q3 24
$0
$0
-$12M
Q4 24
$0
$0
-$9M
Q1 25
$50K
$50K
-$10M
Q2 25
$0
$0
-$25M
Q3 25
$0
-$28K
-$7M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
94.5x
—
Q1 23
142.0x
—
Q2 23
126.7x
—
Q3 23
157.8x
—
Q4 23
228.1x
—
Q1 24
269.9x
—
Q2 24
416.0x
—
Q3 24
841.9x
—
Q4 24
2525.6x
—
Q1 25
707.2x
—
Q2 25
707.2x
—
Q3 25
707.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$6M
-$6M
Q1 23
-$1M
-$1M
Q2 23
-$3M
-$3M
Q3 23
-$4M
-$4M
Q4 23
-$3M
-$3M
Q1 24
-$7M
-$7M
Q2 24
-$8M
-$8M
Q3 24
-$7M
-$7M
Q4 24
-$11M
-$11M
Q1 25
-$7M
-$7M
Q2 25
-$7M
-$8M
Q3 25
-$5M
-$6M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$0
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$706K
Q3 25
$193K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-40.5%
-37.6%
Q1 23
-76.7%
-2.7%
Q2 23
+187.5%
+0.8%
Q3 23
-56.1%
+13.7%
Q4 23
-71.1%
+46.5%
Q1 24
-63.2%
+70.7%
Q2 24
-100.0%
+52.8%
Q3 24
-100.0%
+43.3%
Q4 24
-100.0%
+12.6%
Q1 25
+257.1%
-9.8%
Q2 25
—
+149.1%
Q3 25
—
-39.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$2M
1843.3%
Q1 23
$2M
4571.1%
Q2 23
$2M
4050.0%
Q3 23
$2M
4393.0%
Q4 23
$2M
6710.7%
Q1 24
$2M
12707.1%
Q2 24
$2M
—
Q3 24
$2M
—
Q4 24
$2M
—
Q1 25
$2M
4152.0%
Q2 25
$2M
—
Q3 25
$3M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q4 22
$3M
$2M
$47K
—
Q1 23
$4M
$2M
$43K
—
Q2 23
$4M
$2M
—
—
Q3 23
$6M
$3M
—
—
Q4 23
$6M
$2M
—
—
Q1 24
$9M
$2M
—
—
Q2 24
$7M
$3M
$41K
—
Q3 24
$10M
—
—
$2M
Q4 24
$7M
$2M
—
—
Q1 25
$8M
$2M
—
—
Q2 25
$6M
$2M
—
—
Q3 25
$5M
—
—
$3M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$52M
$0
$52M
Q1 23
$51M
$0
$51M
Q2 23
$48M
$0
$48M
Q3 23
$42M
$0
$42M
Q4 23
$36M
$0
$36M
Q1 24
$26M
$0
$26M
Q2 24
$31M
$0
$31M
Q3 24
$34M
$0
$34M
Q4 24
$21M
$0
$21M
Q1 25
$19M
$0
$19M
Q2 25
$33M
$0
$33M
Q3 25
$28M
$0
$28M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
18M
-0.1%
Q1 23
18M
+0.1%
Q2 23
18M
+0.0%
Q3 23
18M
+0.3%
Q4 23
18M
-0.3%
Q1 24
18M
+0.4%
Q2 24
19M
+7.1%
Q3 24
20M
+4.6%
Q4 24
22M
+10.4%
Q1 25
22M
+1.0%
Q2 25
23M
+3.6%
Q3 25
27M
+14.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
$0
3
FY 19
$0
4
FY 20
$2K
5
FY 21
$18K
10
FY 22
$37K
10
FY 23
$14K
11
FY 24
$1K
13
marketcaparena.com